Allergy to beta-lactam antibiotics in children: Looking for a practical approach

Main Article Content

J.A. Porto

Keywords

Abstract

N/A

Abstract 75 | PDF Downloads 90

References

1. WHO. International drug monitoring: the role of national centres. Report of a WHO meeting. WHO Tech Rep Ser. 1972;498:1-25.

2. Gamboa PM. The epidemiology of drug allergy-related consultations in Spanish Allergology Services: allergologica 2005. J Investig Allergol Clin Immunol. 2009;19 Suppl. 2:45-50.

3. Farnoush H, Pham D, Ben-Shoshan M. Positive penicillin allergy testing results: a systematic review and meta-analysis of papers published from 2010 through 2015. Postgrad Med. 2016;128:557-62.

4. Zambonino MA, Corzo JL, Munoz C, Requena G, Ariza A, Mayorga C, et al. Diagnostic evaluation of hypersensitivity reactions to beta-lactam antibiotics in a large population of children. Pediatr Allergy Immunol. 2014;25:80-7.

5. Caubet JC, Kaiser L, Lamaitre B, Fellay Benoit, Gervaix Alain, Eigenmann Philippe A. The role of penicillin in benign skin rashes in childhood: a prospective study base don drug rechalenge. J Allergy Clin Immunol. 2011;127:218-22.

6. Fernandez TD, Mayorga C, Ariza A, Corzo JL, Torres MJ. Allergic reactions to antibiotics in children. Curr Opin Allergy Clin Immnunol. 2014;14(4):278-85.

7. Bass JW, Crowley DM, Steele RW, Young F, Harden L. Adverse effects of orally administered ampicillin. J Pediatr. 1973;83(July (1)):106-8.

8. Ponvert C, Perrin Y, Bados-Albiero A, Le Bourgeois M, Karila C, Delacourt C, et al. Allergy to beta-lactam antibiotics in children: results of a 20year study based on clinical history, skin and challenge tests. Pediatr Allergy Immunol. 2011;22:411-8.

9. Berroa F, Callero A, Fuentes-Aparicio V, Infante S, AlonsoLebrero E, Zapatero L. J Investig Allergol Clin Immunol. 2013;23(5):369-70.

10. Carder KR. Hypersensitivity reactions in neonates and infants. Dermatol Ther. 2005;18:160-75.

11. Baselga E. Inflammatory and purpuric eruptions. In: Eichenfield LF, Frieden IJ, Esterly NB, editors. Textbook of neonatal dermatology. Philadelphia: WB Saunders; 2001. p. 294-323.

12. Aberer W, Bircher A, Romano A, et al. Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy. 2003;58:854-63.

13. Gomes E, Marques ML, Regateiro FS. Epidemiology and risk factors for severe delayed drug hypersensitivity reactions. Curr Pharm Des. 2019;25:3799-812.

14. Brockow K, Ardern-Jones MR, Mockenhaup M, Aberer W, Barbaud A, Caubet JC, et al. EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity. Allergy. 2019;74:14-27.

15. Moral L, Caubet JC. Oral challenge without skin tests in children with non-severe betalactam hypersensitivity: time to change the paradigm? Pediatr Allergy Immunol. 2017;28:724-7.

16. Atanaskovic-Markovic M, Gaeta F, Medjo B, Gavrovic-Jankulovic M, Velickovic TC, Tmusic V, et al. Non-immediate hypersensitivity reactions to beta-lactam antibiotics in children - our 10-year experience in allergy work-up. Pediatr Allergy Immunol. 2016;27:533-8.